Can DCIS Cause a Lump, Breast Pain, or Nipple Discharge?
At a Glance
DCIS usually causes no symptoms and is often found on a screening mammogram. It can sometimes cause a lump, nipple discharge without squeezing, breast pain, or skin changes; these symptoms do not prove invasive cancer but should be evaluated.
In this answer
3 sections
Most of the time, ductal carcinoma in situ (DCIS) does not cause any symptoms. It is usually discovered during a routine screening mammogram as tiny white specks called calcifications (calcium deposits) [1][2][3]. However, it is possible for DCIS to cause a lump, nipple discharge, or, less commonly, breast pain or skin changes [4][5][6]. While these symptoms can be caused by many different benign (non-cancerous) breast conditions, they are important to report because they change how your care team evaluates your breast.
Symptoms Associated with DCIS
When DCIS is not found through screening, it is most often noticed because of a physical change in the breast [3][5].
- A Lump (Palpable Mass): Feeling a new lump is the most common physical sign of DCIS, though it is still rare in populations with regular screening [4][5].
- Nipple Discharge: DCIS can occasionally cause fluid to leak from the nipple [4]. Discharge is most concerning when it happens on its own without squeezing (spontaneous), comes from only one breast, and is bloody or clear (serous) [6][7].
- Skin Changes or Pain: Breast pain is very common and usually has non-cancerous causes; it is a rare and non-specific symptom of DCIS [5]. Additionally, persistent flaking, crusting, or itching on the nipple and areola can be a sign of Paget’s disease of the breast. This is a separate, distinct condition that is often associated with underlying DCIS or invasive cancer [8].
When to take action: If you notice a new lump, spontaneous nipple discharge, or persistent skin changes, contact your care team for an evaluation. These do not automatically mean you have cancer, but they require assessment.
Do Symptoms Mean There is Invasive Cancer?
If you were diagnosed with DCIS after noticing a symptom, you might wonder if that means the cancer is already invasive. Invasive breast cancer means the cells have grown through the milk duct wall into the nearby breast tissue. It does not necessarily mean the cancer has spread to your lymph nodes or distant parts of your body.
When a needle biopsy shows only DCIS, but the entire area is later removed during surgery, doctors sometimes find a hidden area of invasive cancer. This is called being upstaged.
Some studies estimate that, on average, about 1 in 4 cases of biopsy-diagnosed DCIS are upstaged at surgery [9]. However, this is a broad population statistic, not your personal risk. Your individual likelihood depends on several factors. Having certain physical symptoms can increase the chance of finding hidden invasion:
- Palpable Lumps: Studies, including a large multicenter analysis, show that when DCIS forms a lump you can feel, there is a higher chance of upstaging during surgery [10][9].
- Bloody Discharge: Bloody nipple discharge has also been linked in some studies to an increased risk of hidden invasion, though the research is mixed [11][12].
A symptom alone does not guarantee invasive cancer. Doctors combine your symptoms with other details to estimate risk, such as:
- The size of the suspicious area on imaging [9][10].
- Whether the imaging shows a discrete mass (a distinct, solid lump on the image) rather than just calcifications [10][13].
- High nuclear grade (how abnormal the cells look under a microscope) and the presence of comedonecrosis (dead cancer cells inside the duct) [9][14].
Next Steps When You Have Symptoms
Because symptoms can increase the chance of hidden invasive cancer, they usually prompt a more thorough evaluation [10]. Your care team may recommend additional imaging, such as a diagnostic mammogram or a targeted ultrasound (an ultrasound focused on the specific area of your symptom), to see if there is a distinct mass [10]. In select cases, a breast MRI might be used to map the extent of the disease, though it is not routine for everyone and can sometimes flag non-cancerous areas.
While imaging helps guide treatment, it cannot reliably prove or rule out microscopic invasion. A needle biopsy only samples a portion of the area. The definitive answer regarding whether any invasive cancer is present comes from examining the entire tissue removed during surgery. Depending on the concern for invasion, your surgeon may also discuss whether to test your lymph nodes during the operation.
Common questions in this guide
Can ductal carcinoma in situ cause a lump I can feel?
Is breast pain a sign of DCIS?
What kind of nipple discharge should be checked?
Do a lump or bloody discharge mean that my DCIS is invasive?
What tests might I need if I have DCIS symptoms?
Could symptoms change whether my lymph nodes are tested?
Related questions
Get notified when new evidence is published on ductal breast carcinoma in situ.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment.
Shehata M, Grimm L, Ballantyne N, et al.
Journal of breast imaging 2019; (1(3)):166-176 doi:10.1093/jbi/wbz039.
PMID: 31538141 - 2
Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Koh VC, Lim JC, Thike AA, et al.
Breast cancer research and treatment 2015; (152(2)):293-304 doi:10.1007/s10549-015-3472-6.
PMID: 26077641 - 3
Unraveling Ductal Carcinoma In Situ in an Unscreened Population: Understanding Its Natural History Through Advanced Presentation and Management.
Ali Q, Niaz R, Soomro R
Cureus 2025; (17(3)):e80950 doi:10.7759/cureus.80950.
PMID: 40255704 - 4
Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
Venkatesh SL, Oseni TO, Bahl M
Clinical imaging 2021; (73()):101-107 doi:10.1016/j.clinimag.2020.11.050.
PMID: 33360004 - 5
Clinical presentations and outcomes of young women aged <40 yrs with Ductal carcinoma in situ.
Yan Z, Ngeow J, Allen J, Lim GH
Breast disease 2023; (42(1)):299-303 doi:10.3233/BD-230018.
PMID: 37807772 - 6
Breast imaging in patients with nipple discharge.
de Paula IB, Campos AM
Radiologia brasileira 2017; (50(6)):383-388 doi:10.1590/0100-3984.2016.0103.
PMID: 29307929 - 7
Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge.
Ward K, Selvarajah G, Al-Omishy H, et al.
Annals of the Royal College of Surgeons of England 2024; (106(6)):515-520 doi:10.1308/rcsann.2022.0093.
PMID: 38497796 - 8
Male Mammary Paget Disease: A Tale of 2 Contrasting Cases.
Roy M, Teshome M, Damodaran S, et al.
The American Journal of dermatopathology 2020; (42(12)):981-985 doi:10.1097/DAD.0000000000001799.
PMID: 33289978 - 9
Precise application of sentinel lymph node biopsy in patients with ductal carcinoma in situ: A systematic review and meta-analysis of real-world data.
Chiu CW, Chang LC, Su CM, et al.
Surgical oncology 2022; (45()):101880 doi:10.1016/j.suronc.2022.101880.
PMID: 36332555 - 10
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K, Masuda N, Hayashi N, et al.
Breast cancer (Tokyo, Japan) 2021; (28(4)):896-903 doi:10.1007/s12282-021-01225-0.
PMID: 33599914 - 11
Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.
Shimoyama K, Osako T, Mitsuhashi T, et al.
Acta medica Okayama 2017; (71(3)):233-240 doi:10.18926/AMO/55206.
PMID: 28655943 - 12
Predictors of Malignancy for Female Patients with Suspicious Nipple Discharge: A Retrospective Study.
Jin L, Zhu L, Li S, et al.
Anticancer research 2017; (37(8)):4655-4658 doi:10.21873/anticanres.11868.
PMID: 28739767 - 13
Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer.
Park KW, Kim SW, Han H, et al.
NPJ breast cancer 2022; (8(1)):8 doi:10.1038/s41523-021-00364-z.
PMID: 35031626 - 14
Predictive Histopathological Markers for Upstaging to Invasive Carcinoma after a Biopsy Diagnosis of Ductal Carcinoma in situ of the Breast: A Hypothesis-Generating Systematic Review.
Riggi JAM, Kassem I, Galant C, et al.
Pathobiology : journal of immunopathology, molecular and cellular biology 2026; (93(1)):34-47 doi:10.1159/000547335.
PMID: 40716433
This page explains symptoms that may occur with DCIS and how they can affect evaluation for informational purposes only; it does not replace medical advice. Contact your breast care team about any new lump, nipple discharge, persistent pain, or skin change.